SCHEMBL97819

SCHEMBL97819

O=[C]c1ccc2nccnc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.38
MEN1 O00255 6/20 0.38
MAPT P10636 5/20 0.38
POLB P06746 4/20 0.38
ALDH1A1 P00352 6/20 0.38
HPGD P15428 5/20 0.38
KDM4E B2RXH2 4/20 0.38
TP53 P04637 3/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 8/20 0.37
RAB9A P51151 8/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 2/20 0.35
GLA P06280 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2C P18825 1/20 0.35
CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6854298 0.78 ERN1 (0.35) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL738274 0.77 HDAC8 (0.41) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL622637 0.77 CDK5 (0.47) ALDH1A1KDM4EGAAGLADYRK1B
Methane SCHEMBL28258537 0.76 CDK5 (0.46) ALDH1A1KDM4EGAAGLADYRK1B
SCHEMBL2005235 0.75 ALDH1A1 (0.39) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL2009640 0.75 NPC1 (0.57) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL2012058 0.75 ALDH1A1 (0.53) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL6156262 0.74 KMT2A (0.33) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL7087038 0.72 ALDH1A1 (0.47) ALDH1A1
SCHEMBL5674897 0.72 ALDH1A1 (0.47) ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120116027-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2012-05-10 US claimed
CN-102216325-A Method for purifying human growth hormone polypeptides using affinity resins comprising specific ligands NOVO NORDISK AS 2011-10-12 CN claimed
EP-2356141-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS Novo Nordisk A/S (DK) 2011-08-17 EP claimed
WO-2010055135-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2010-05-20 WO claimed
US-4413999-A CHROMATOGRAPHY, BIOCHEMICAL IMMOBILIZATION, FIBER REACTIVE DYES RESEARCH PRODUCTS REHOVOT LTD. (IL) 1983-11-08 US claimed
CN-106458934-B Quinoxaline compounds and application thereof 米伦纽姆医药公司 2019-08-16 CN disclosed
CN-107245056-A Chemical entities, composition and method 润新生物公司 2017-10-13 CN disclosed
CN-103764140-B Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases 韩国化学研究院 2017-05-17 CN disclosed
CN-106458934-A Quinoxaline compounds and uses thereof 米伦纽姆医药公司 2017-02-22 CN disclosed
EP-2440517-B1 CYCLOALKYLCARBAMATE BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS GILEAD SCIENCES INC (US) 2014-03-26 EP disclosed
US-8394974-B2 Process for producing optically active chromene oxide compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-03-12 US disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
WO-2005090357-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-29 WO disclosed
CN-1104227-A Reactive dyes, their preparation and their use CIBA GEIGY AG (CH) 1995-06-28 CN disclosed
CN-1087694-A Use anionic textile dyes, on modified fiber materials, make the method for product dyed thereby with the ink jet printing technique HOECHST AG (DE) 1994-06-08 CN disclosed
CN-1005738-B Printing method for cellulose fabric 西巴·盖尔基股份公司 1989-11-08 CN disclosed
US-4757137-A Orthotrifluoromethyl containing phenylazonaphthol dyestuffs BAYER AKTIENGESELLSCHAFT (DE) 1988-07-12 US disclosed
CN-85107872-A The printing method of cellulose fibre (fabric) 1986-07-09 CN disclosed
EP-0135630-A1 Amidoxime derivatives, processes for the preparation thereof and uses therefor RESEARCH PRODUCTS REHOVOT LTD. (IL) 1985-04-03 EP disclosed
US-4413999-A CHROMATOGRAPHY, BIOCHEMICAL IMMOBILIZATION, FIBER REACTIVE DYES RESEARCH PRODUCTS REHOVOT LTD. (IL) 1983-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120116027-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS GHRHR, GHITM, GHSR KMT2A 3404/4885MEN1 1365/4885MAPT 4457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.